Table 3 Comparison between the predisposed hosts and normal hosts (N = 34)
Normal hosts (%) (n = 26) | Predisposed hosts (%) (n = 8) | P | |
|---|---|---|---|
Age (year) | 5 (3–9) | 7 (4–10) | 0.900 |
Sex (Male: Female) | 19:7 | 1:1 | 0.388 |
Area (rural) | 21 (80.8) | 5 (62.5) | 0.355 |
Contacting history | 10 (38.5) | 5 (62.5) | 0.417 |
Time to diagnosis (day) | 30 (20–56) | 25 (13–56) | 0.759 |
Hospitalization (day) | 41 ± 25 | 53 ± 44 | 0.352 |
Daily cost (RMB) | 846 (567–1615) | 1080 (621–1080) | 0.138 |
Disseminated cryptococcosis | 14 (53.8) | 2 (25.0) | 0.233 |
Manifestations | |||
Fever | 39.2 ± 0.7 | 38.9 ± 0.8 | 0.242 |
Headache | 14 (53.8) | 7 (87.5) | 0.116 |
Vomiting | 14 (53.8) | 7 (87.5) | 0.116 |
Altered mental status | 5 (19.2) | 5 (62.5) | 0.031* |
Seizure | 4 (15.4) | 5 (62.5) | 0.017* |
Vision damage | 4 (15.4) | 4 (50.0) | 0.066 |
Neck stiffness | 13 (50.0) | 5 (62.5) | 0.693 |
Blood | |||
WBC (×109/L) | 12.4 (8.6–16.3) | 10.2 (8.8–11.3) | 0.274 |
CRP (mg/L) | 11.9 (0–63.5) | 16 (0–30.9) | 0.592 |
ESR (mm/h) | 50 (26–79) | 10 (1–52) | 0.037* |
EO (×109/L) | 0.72 (0.31–1.77) | 0.38 (0.2–1.24) | 0.504 |
CSF | |||
WBC (×106/L) | 32 (10–113) | 25 (7–102) | 0.313 |
Glu (mmol/L) | 2.24 ± 1.23 | 2.80 ± 1.92 | 0.332 |
Pro (mg/L) | 625 (436–890) | 660 (386–938) | 0.528 |
Prognosis | |||
Success at discharge | 16 (61.5) | 6 (75.0) | 0.618 |
Success at follow-up | 4/10 (40.0) | 3/5 (60.0) | 0.608 |